The emerging treatment of tirzepatide peptide represents a major development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide169634.blogocial.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-78173994